𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)

✍ Scribed by Hilde Marsé; Eric Van Cutsem; Axel Grothey; Sonia Valverde

Book ID
116436423
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
563 KB
Volume
8
Category
Article
ISSN
1462-3889

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term management of DBS in dystonia:
Long-Term management of DBS in dystonia: Response to stimulation, adverse events, battery changes, and special considerations
✍ Michele Tagliati; Paul Krack; Jens Volkmann; Tipu Aziz; Joachim K. Krauss; Andre 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

## Abstract Multiple independent case series have documented sustained benefit of bilateral pallidal deep brain stimulation (DBS) up to 3 years in patients with primary dystonia. Growing evidence exists for positive outcomes extending up to 10 years. The beneficial effects from DBS are usually repo